JAGX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
JAGX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.
Jaguar Health's quarterly accumulated depreciation increased from Sep. 2023 ($-0.45 Mil) to Dec. 2023 ($-0.47 Mil) and increased from Dec. 2023 ($-0.47 Mil) to Mar. 2024 ($-0.48 Mil).
Jaguar Health's annual accumulated depreciation increased from Dec. 2021 ($-0.30 Mil) to Dec. 2022 ($-0.40 Mil) and increased from Dec. 2022 ($-0.40 Mil) to Dec. 2023 ($-0.47 Mil).
The historical data trend for Jaguar Health's Accumulated Depreciation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaguar Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Accumulated Depreciation | Get a 7-Day Free Trial | -0.23 | -0.27 | -0.30 | -0.40 | -0.47 |
Jaguar Health Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Accumulated Depreciation | Get a 7-Day Free Trial | -0.42 | -0.44 | -0.45 | -0.47 | -0.48 |
The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.
Thank you for viewing the detailed overview of Jaguar Health's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.
Anula Jayasuriya | director | 5150 EL CAMINO REAL, SUITE #A-32, LOS ALTOS CA 94022 |
Pravin R Chaturvedi | officer: Chief Scientific Officer | C/O JAGUAR HEALTH INC., 200 PINE STREET, SUITE 400, SAN FRANCISCO CA 94104 |
Lisa A Conte | director, officer: CEO & President | 213 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080 |
Carol R. Lizak | officer: Chief Accounting Officer | 201 MISSION STREET, SUITE 2375, SAN FRANCISCO CA 94105 |
James J Bochnowski | director | C/O DELPHI VENTURES, 160 BOVET RD, SUITE 408, SAN MATEO CA 94402 |
Jonathan S. Wolin | officer: Chief of Staff, CCO & GC | 201 MISSION STREET, SUITE 2375, SAN FRANCISCO CA 94105 |
Jonathan B. Siegel | director | C/O KINGDON CAPITAL MANAGEMENT, L.L.C., 152 WEST 57TH STREET, 50TH FLOOR, NEW YORK NY 10019 |
Bryan Ezralow 1994 Trust Dated December 22, 1994 | 10 percent owner | 23622 CALABASAS ROAD, SUITE 200, CALABASAS CA 91302 |
Bryan Ezralow | 10 percent owner | THE EZRALOW CO, LLC, 23622 CALABASAS ROAD, SUITE 200, CALABASAS CA 91302-1549 |
Nantucket Investments Ltd | 10 percent owner | PO BOX 282, REGENCY COURT, GLATEGNY ESPLANADE, ST PETER PORT Y7 GY1 3RH |
Jonathan M Glaser | 10 percent owner | 11601 WILSHIRE BLVD., SUITE 2180, LOS ANGELES CA 90025 |
Murray David Macnaughtan | director | C/O JAGUAR HEALTH, INC., 201 MISSION STREET, SUITE 2375, SAN FRANCISCO CA 94105 |
Greg J Divis | director | 10-1 BLANCHARDSTOWN CORPORATE PARK, BALLYCOOLIN, DUBLIN L2 15 |
Jeffery C. Johnson | director | C/O SAGARD CAPITAL PARTNERS, L.P., 280 PARK AVENUE, 3F WEST, STAMFORD CT 06901 |
Sagard Capital Partners, L.p. | 10 percent owner | 280 PARK AVENUE, 3RD FLOOR WEST, NEW YORK NY 10017 |
From GuruFocus
By ACCESSWIRE • 12-07-2023
By ACCESSWIRE • 11-21-2023
By ACCESSWIRE • 08-14-2023
By ACCESSWIRE • 11-02-2023
By ACCESSWIRE • 09-28-2023
By ACCESSWIRE • 08-10-2023
By ACCESSWIRE • 12-04-2023
By ACCESSWIRE • 09-07-2023
By ACCESSWIRE • 10-19-2023
By ACCESSWIRE • 10-26-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.